In adults with overweight or obesity, taking 2.4 mg of pemvidutide once a week leads to more weight loss than taking 1.2 mg or 1.8 mg weekly, suggesting that higher doses produce greater effects.
Mechanism
Synthesis from 1 study
More of this drug means it hits more of the right spots in your brain and liver — making you eat less and burn more calories. That’s why the highest dose leads to the most weight loss.
Most probable mechanism
Higher doses of the drug activate more receptors in the brain and liver, making you feel fuller faster and causing your body to burn more calories, which leads to more weight loss.
Pemvidutide binds to GLP-1 receptors on hypothalamic neurons, reducing hunger signals and increasing feelings of fullness
Pemvidutide simultaneously activates glucagon receptors on hepatocytes, increasing liver-based energy expenditure and fat oxidation
Higher drug concentrations lead to greater receptor activation across both pathways, amplifying reductions in food intake and increases in calorie burning
The combined effect creates a sustained negative energy balance, resulting in greater weight loss at higher doses
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.